Literature DB >> 33713296

The association of continuous-use medications and sleep parameters in a sample of working adults.

Marcela Zambrim Campanini1, Alberto Duran González1, Selma Maffei de Andrade1, Edmarlon Girotto1, Marcos Aparecido Sarriá Cabrera1, Iván Cavero-Redondo2, Arthur Eumann Mesas3,4.   

Abstract

PURPOSE: Although polypharmacy is linked to health outcomes in the elderly, the use of multiple medications is increasing in middle-aged adults. This study analyzed whether or not the increased number of continuous-use medications (C-UM) is associated with objective and subjective sleep parameters in a working population.
METHODS: Cross-sectional study with schoolteachers from public schools in Londrina, Brazil. The participants were classified according to the self-reported number of C-UM. Sleep data were obtained with actigraphy and a concomitant sleep diary for 7 days. The analyses were adjusted for socio-demographic, lifestyle, and morbidity variables.
RESULTS: A total of 17% of the participants were classified as using ≥3C-UM. In fully adjusted analyses, the use of ≥3C-UM was associated with lower actigraphic sleep duration (<6 h) (odds ratio [OR] = 2.51; 95% confidence interval [CI] = 1.01,6.21), higher actigraphic sleep onset latency (SOL) (OR = 2.65; 95%CI = 1.00,7.02), and with a higher number of awakenings during sleep measured by actigraphy (OR = 3.30; 95%CI = 1.32,8.28). The use of ≥3 C-UM was also associated with higher SOL (OR = 3.76; 95%CI = 1.36,10.5) and lower sleep efficiency (OR = 11.6; 95%CI = 2.92,46.1), as measured with the sleep diary. A 1-unit increment in the number of continuous-use medications was associated with higher self-reported SOL and lower subjective sleep efficiency.
CONCLUSION: The continuous use of ≥3 medications is associated with worse objective and subjective parameters of sleep duration and quality in schoolteachers.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Actigraphy; Drug therapy; Epidemiology; Polypharmacy; Schoolteachers; Sleep

Mesh:

Year:  2021        PMID: 33713296     DOI: 10.1007/s11325-021-02343-x

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  21 in total

1.  Agreement between sleep diary and actigraphy in a highly educated Brazilian population.

Authors:  Marcela Zambrim Campanini; Esther Lopez-Garcia; Fernando Rodríguez-Artalejo; Alberto Durán González; Selma Maffei Andrade; Arthur Eumann Mesas
Journal:  Sleep Med       Date:  2017-04-25       Impact factor: 3.492

Review 2.  Short sleep duration and health outcomes: a systematic review, meta-analysis, and meta-regression.

Authors:  Osamu Itani; Maki Jike; Norio Watanabe; Yoshitaka Kaneita
Journal:  Sleep Med       Date:  2016-08-26       Impact factor: 3.492

3.  Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews.

Authors:  Laurie E Davies; Gemma Spiers; Andrew Kingston; Adam Todd; Joy Adamson; Barbara Hanratty
Journal:  J Am Med Dir Assoc       Date:  2020-01-08       Impact factor: 4.669

4.  Relationships between polypharmacy and the sleep cycle among active-duty service members.

Authors:  R Gregory Lande; Cynthia Gragnani
Journal:  J Am Osteopath Assoc       Date:  2015-06

5.  Sleep disorders and work performance: findings from the 2008 National Sleep Foundation Sleep in America poll.

Authors:  Leslie M Swanson; J Todd Arnedt; Mark R Rosekind; Gregory Belenky; Thomas J Balkin; Christopher Drake
Journal:  J Sleep Res       Date:  2010-09-30       Impact factor: 3.981

6.  Psychosocial correlates of aspects of sleep quality in community-dwelling Irish older adults.

Authors:  J E McHugh; A-M Casey; B A Lawlor
Journal:  Aging Ment Health       Date:  2011-05-24       Impact factor: 3.658

Review 7.  Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review.

Authors:  Terri R Fried; John O'Leary; Virginia Towle; Mary K Goldstein; Mark Trentalange; Deanna K Martin
Journal:  J Am Geriatr Soc       Date:  2014-12       Impact factor: 5.562

Review 8.  Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many.

Authors:  Cathal A Cadogan; Cristín Ryan; Carmel M Hughes
Journal:  Drug Saf       Date:  2016-02       Impact factor: 5.606

Review 9.  Developing a measure of polypharmacy appropriateness in primary care: systematic review and expert consensus study.

Authors:  Jenni Burt; Natasha Elmore; Stephen M Campbell; Sarah Rodgers; Anthony J Avery; Rupert A Payne
Journal:  BMC Med       Date:  2018-06-13       Impact factor: 8.775

Review 10.  What is polypharmacy? A systematic review of definitions.

Authors:  Nashwa Masnoon; Sepehr Shakib; Lisa Kalisch-Ellett; Gillian E Caughey
Journal:  BMC Geriatr       Date:  2017-10-10       Impact factor: 4.070

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.